• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿性关节炎和骨关节炎患者培养滑膜细胞中白细胞介素-1受体拮抗剂的产生

Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis.

作者信息

Fujikawa Y, Shingu M, Torisu T, Masumi S

机构信息

Department of Orthopaedic Surgery, Oita Medical University, Japan.

出版信息

Ann Rheum Dis. 1995 Apr;54(4):318-20. doi: 10.1136/ard.54.4.318.

DOI:10.1136/ard.54.4.318
PMID:7763113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1005582/
Abstract

OBJECTIVE

To measure the amounts of interleukin-1 receptor antagonist (IL-1ra) protein produced by cultured synovial cells obtained from patients with rheumatoid arthritis (RA) and osteoarthritis (OA).

METHODS

Synovial cells obtained from patients with either RA or OA were cultured and the supernatants were measured for IL-1ra by enzyme linked immunosorbent assay.

RESULTS

The synovial cells obtained from patients with RA produced significantly smaller amounts of IL-1ra than did those obtained from patients with OA, in a late passage (third to fifth) without stimulation and a first passage both with and without stimulation (p < 0.025, respectively). In addition, when the patients with RA were divided into two groups according to the maximum number of lining cell layers, the amounts of IL-1ra produced by the proliferative type were smaller than those produced by the less proliferative type (p < 0.025).

CONCLUSIONS

The above findings suggest that IL-1ra production in RA synovial cells is suppressed, and that reduced IL-1ra protein production is one of the causes which leads to the proliferation of lining cells and persistent joint inflammation.

摘要

目的

测量从类风湿关节炎(RA)和骨关节炎(OA)患者获取的培养滑膜细胞产生的白细胞介素-1受体拮抗剂(IL-1ra)蛋白量。

方法

培养从RA或OA患者获取的滑膜细胞,通过酶联免疫吸附测定法测量上清液中的IL-1ra。

结果

在未刺激的晚期传代(第三代至第五代)以及有刺激和无刺激的第一代传代中,从RA患者获取的滑膜细胞产生的IL-1ra量显著少于从OA患者获取的滑膜细胞(p分别<0.025)。此外,当根据衬里细胞层的最大数量将RA患者分为两组时,增殖型产生的IL-1ra量少于增殖较少型(p<0.025)。

结论

上述发现表明,RA滑膜细胞中IL-1ra的产生受到抑制,IL-1ra蛋白产生减少是导致衬里细胞增殖和持续性关节炎症的原因之一。

相似文献

1
Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis.类风湿性关节炎和骨关节炎患者培养滑膜细胞中白细胞介素-1受体拮抗剂的产生
Ann Rheum Dis. 1995 Apr;54(4):318-20. doi: 10.1136/ard.54.4.318.
2
Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis.白细胞介素-1α、1型白细胞介素-1受体及白细胞介素-1受体拮抗剂在类风湿关节炎滑膜及软骨/血管翳交界处的定位
Br J Rheumatol. 1992 Dec;31(12):801-9. doi: 10.1093/rheumatology/31.12.801.
3
Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis.类风湿关节炎中的滑膜白细胞介素-1受体拮抗剂与白细胞介素-1平衡
Arthritis Rheum. 1994 May;37(5):644-52. doi: 10.1002/art.1780370507.
4
Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane.类风湿关节炎滑膜中的白细胞介素-1、白细胞介素-1受体拮抗剂与巨噬细胞群体
Br J Rheumatol. 1997 Sep;36(9):935-40. doi: 10.1093/rheumatology/36.9.935.
5
Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10.类风湿性滑膜中白细胞介素-1受体拮抗剂/白细胞介素-1β的平衡及其受白细胞介素-4和白细胞介素-10的调节
J Immunol. 1995 Feb 1;154(3):1432-9.
6
Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process.人骨关节炎滑膜中金属蛋白酶和白细胞介素6(IL-6)的合成是一个IL-1介导的过程。
J Rheumatol Suppl. 1995 Feb;43:109-14.
7
An investigation of cell proliferation and soluble mediators induced by interleukin 1beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis.白细胞介素1β诱导人滑膜成纤维细胞的细胞增殖及可溶性介质的研究:骨关节炎与类风湿关节炎的比较反应
Inflamm Res. 2001 Feb;50(2):65-72. doi: 10.1007/s000110050726.
8
IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium.类风湿关节炎和骨关节炎滑膜中白细胞介素-1受体拮抗剂蛋白的产生及基因表达
J Immunol. 1992 Aug 1;149(3):1054-62.
9
Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.胶原诱导性关节炎小鼠滑膜中I型细胞内白细胞介素-1受体拮抗剂产生增加:在关节炎消退中的可能作用
Arthritis Rheum. 2001 Feb;44(2):451-62. doi: 10.1002/1529-0131(200102)44:2<451::AID-ANR64>3.0.CO;2-H.
10
Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes--regulation by IFN-gamma and IL-4.类风湿性和骨关节炎滑膜细胞产生白细胞介素-1受体拮抗剂、炎症趋化蛋白和前列腺素E——受γ干扰素和白细胞介素-4调控
J Immunol. 1994 Feb 15;152(4):2060-5.

引用本文的文献

1
Susceptibility of cyclin-dependent kinase inhibitor 1-deficient mice to rheumatoid arthritis arising from interleukin-1β-induced inflammation.细胞周期蛋白依赖性激酶抑制剂 1 缺陷小鼠对白细胞介素-1β诱导的炎症引起的类风湿关节炎的易感性。
Sci Rep. 2021 Jun 15;11(1):12516. doi: 10.1038/s41598-021-92055-9.
2
The role of synovitis in osteoarthritis pathogenesis.滑膜炎在骨关节炎发病机制中的作用。
Bone. 2012 Aug;51(2):249-57. doi: 10.1016/j.bone.2012.02.012. Epub 2012 Feb 22.
3
Durability and rapidity of response to anakinra in patients with rheumatoid arthritis.类风湿关节炎患者对阿那白滞素反应的持久性和快速性。
Drugs. 2004;64(22):2493-501. doi: 10.2165/00003495-200464220-00001.
4
Current and future management approaches for rheumatoid arthritis.类风湿关节炎的当前及未来管理方法
Arthritis Res. 2002;4 Suppl 2(Suppl 2):S16-21. doi: 10.1186/ar548. Epub 2002 Mar 27.
5
Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis.丙型肝炎病毒(HCV)相关慢性肝炎肝组织中白细胞介素-1β(IL-1β)与白细胞介素-1受体拮抗剂mRNA的失衡
Clin Exp Immunol. 1999 Mar;115(3):515-20. doi: 10.1046/j.1365-2249.1999.00837.x.

本文引用的文献

1
Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Potential contribution from synovial fluid neutrophils.类风湿关节炎及其他关节病中滑液白细胞介素-1受体拮抗剂的水平。滑液中性粒细胞的潜在作用。
Arthritis Rheum. 1993 Jun;36(6):781-9. doi: 10.1002/art.1780360607.
2
Interleukin 1, a potential regulator of fibroblast proliferation.白细胞介素1,一种成纤维细胞增殖的潜在调节因子。
J Immunol. 1982 May;128(5):2177-82.
3
Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.骨关节炎分类及报告标准的制定。膝关节骨关节炎的分类。美国风湿病协会诊断与治疗标准委员会。
Arthritis Rheum. 1986 Aug;29(8):1039-49. doi: 10.1002/art.1780290816.
4
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.美国风湿病协会1987年修订的类风湿关节炎分类标准。
Arthritis Rheum. 1988 Mar;31(3):315-24. doi: 10.1002/art.1780310302.
5
Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.人重组白细胞介素1刺激人滑膜细胞产生胶原酶和前列腺素E2。
J Clin Invest. 1986 Feb;77(2):645-8. doi: 10.1172/JCI112350.
6
Interleukin-1 and its biologically related cytokines.白细胞介素-1及其生物学相关细胞因子。
Adv Immunol. 1989;44:153-205. doi: 10.1016/s0065-2776(08)60642-2.
7
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.类风湿关节炎中的细胞因子及细胞因子抑制剂或拮抗剂
Arthritis Rheum. 1990 Mar;33(3):305-15. doi: 10.1002/art.1780330302.
8
Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes.慢性炎症性关节炎中的细胞因子。V. 干扰素-γ与肿瘤坏死因子-α对类风湿关节炎滑膜细胞HLA-DR表达、增殖、胶原酶产生及粒细胞巨噬细胞集落刺激因子产生的相互拮抗作用
J Clin Invest. 1990 Dec;86(6):1790-8. doi: 10.1172/JCI114908.
9
Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs.类风湿关节炎和骨关节炎中的滑膜组织学与免疫病理学。抗风湿药物的体内作用。
Arthritis Rheum. 1991 Feb;34(2):153-63. doi: 10.1002/art.1780340205.
10
Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.
J Clin Invest. 1991 Nov;88(5):1445-51. doi: 10.1172/JCI115453.